Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Instil Bio, Inc. Director's Dealing 2021

Mar 25, 2021

33728_dirs_2021-03-25_6c21ed4e-a174-4b4a-9d04-7ade95448b37.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Instil Bio, Inc. (TIL)
CIK: 0001789769
Period of Report: 2021-03-23

Reporting Person: Shah Nimish P (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-03-23 Common Stock C 5100866 Acquired 5100866 Indirect
2021-03-23 Common Stock C 510030 Acquired 510030 Indirect
2021-03-23 Common Stock C 430431 Acquired 5531297 Indirect
2021-03-23 Common Stock C 43033 Acquired 553063 Indirect
2021-03-23 Common Stock C 480716 Acquired 480716 Indirect
2021-03-23 Common Stock P 104640 $20.00 Acquired 5635937 Indirect
2021-03-23 Common Stock P 10470 $20.00 Acquired 563533 Indirect
2021-03-23 Common Stock P 116880 $20.00 Acquired 597596 Indirect
2021-03-23 Common Stock P 48390 $20.00 Acquired 48390 Indirect
2021-03-23 Common Stock P 19620 $20.00 Acquired 19620 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-03-23 Series B Preferred Stock $ C 4250722 Disposed Common Stock (5100866) Indirect
2021-03-23 Series B Preferred Stock $ C 425025 Disposed Common Stock (510030) Indirect
2021-03-23 Series C Preferred Stock $ C 358693 Disposed Common Stock (430431) Indirect
2021-03-23 Series C Preferred Stock $ C 35861 Disposed Common Stock (43033) Indirect
2021-03-23 Series C Preferred Stock $ C 400597 Disposed Common Stock (480716) Indirect

Footnotes

F1: Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common
Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date.

F2: The securities are held by Venrock Healthcare Capital Partners III, L.P. ("Partners III"). VHCP Management III, LLC ("Management III") is the
sole general partner of Partners III. The Reporting Person is a voting member of Management III and may be deemed to share voting and
investment power with respect to the shares held by Partners III and disclaims Section 16 beneficial ownership of such securities held by
Partners III, except to the extent of his pecuniary interest therein, if any.

F3: The shares are held by VHCP Co-Investment Holdings III, LLC ("Holdings III"). Management III is the manager of Holdings III. The Reporting
Person is a voting member of Management III and may be deemed to share voting and investment power with respect to the shares held by
Holdings III and disclaims Section 16 beneficial ownership of such securities held by Holdings III, except to the extent of his pecuniary interest
therein, if any.

F4: The securities are held by Venrock Healthcare Capital Partners EG, L.P. ("Partners EG"). VHCP Management EG, LLC ("Management EG") is
the sole general partner of Partners EG. The Reporting Person is a voting member of Management EG and may be deemed to share voting and
investment power with respect to the shares held by Partners EG and disclaims Section 16 beneficial ownership of such securities held by
Partners EG, except to the extent of his pecuniary interest therein, if any.

F5: The securities are held by Venrock Healthcare Capital Partners II, L.P. ("Partners II"). VHCP Management II, LLC ("Management II") is the sole general partner of Partners II. The Reporting Person is a voting member of Management II and may be deemed to share voting and investment power with respect to the shares held by Partners II and disclaims Section 16 beneficial ownership of such securities held by Partners II, except to the extent of his pecuniary interest therein, if any.

F6: The shares are held by VHCP Co-Investment Holdings II, LLC ("Holdings II"). Management II is the manager of Holdings II. The Reporting Person is a voting member of Management II and may be deemed to share voting and investment power with respect to the shares held by Holdings II and disclaims Section 16 beneficial ownership of such securities held by Holdings II, except to the extent of his pecuniary interest therein, if any.